Canada markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
29.85-0.65 (-2.13%)
At close: 04:00PM EDT
29.14 -0.71 (-2.38%)
After hours: 05:23PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 821.42M
Enterprise Value 564.95M
Trailing P/E N/A
Forward P/E 2.48
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.36
Price/Book (mrq)3.11
Enterprise Value/Revenue 5.11
Enterprise Value/EBITDA -2.04

Trading Information

Stock Price History

Beta (5Y Monthly) 2.65
52-Week Change 37.96%
S&P500 52-Week Change 328.04%
52 Week High 343.81
52 Week Low 317.52
50-Day Moving Average 330.56
200-Day Moving Average 329.38

Share Statistics

Avg Vol (3 month) 3509.94k
Avg Vol (10 day) 3429.27k
Shares Outstanding 526.93M
Implied Shares Outstanding 627.52M
Float 824.58M
% Held by Insiders 18.74%
% Held by Institutions 198.74%
Shares Short (Apr 30, 2024) 44.92M
Short Ratio (Apr 30, 2024) 410.32
Short % of Float (Apr 30, 2024) 428.72%
Short % of Shares Outstanding (Apr 30, 2024) 418.26%
Shares Short (prior month Mar 28, 2024) 44.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 16, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 16, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -86.16%
Operating Margin (ttm)-77.90%

Management Effectiveness

Return on Assets (ttm)-17.22%
Return on Equity (ttm)-36.17%

Income Statement

Revenue (ttm)124.53M
Revenue Per Share (ttm)4.66
Quarterly Revenue Growth (yoy)-52.70%
Gross Profit (ttm)N/A
EBITDA -119.29M
Net Income Avi to Common (ttm)-107.3M
Diluted EPS (ttm)-3.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)288.4M
Total Cash Per Share (mrq)10.71
Total Debt (mrq)31.92M
Total Debt/Equity (mrq)12.09%
Current Ratio (mrq)3.26
Book Value Per Share (mrq)9.81

Cash Flow Statement

Operating Cash Flow (ttm)12.21M
Levered Free Cash Flow (ttm)-4.99M